- Home
- / Weiguang Biological
Weiguang Biological
Stock Price
¥28
2024-10-29
Market Capitalization
¥6.3 B
2024-10-29
Revenue
¥1.2 B
FY, 2025
Weiguang Biological Summary
Company Summary
- Overview
- Weiguang Biological is a company that manufactures blood products. It offers human serum albumin and intravenous human immunoglobulin. The company provides R&D, production, and sales services.
- Type
- Public
- Status
- Active
- Founded
- 1985
- HQ
- Shenzhen, CN | view all locations
- Website
- http://www.szwg.com
- Cybersecurity rating
Table of Contents
Key People
Chen Guanqun, Financial Director
Guo Caiping, General Manager
Wu Yusheng, Chairman of the Supervisory Board
LocationsView all
1 location detected
Shenzhen, Guang Dong Sheng HQ
China
No.3402, Guangqiao Avenue
Weiguang Biological Financials
Summary Financials
- Revenue (Q1, 2026)
- ¥219.5M
- Gross profit (Q1, 2026)
- ¥81.3M
- Net income (Q1, 2026)
- ¥30.8M
- Cash (Q1, 2026)
- ¥76.6M
- EBIT (Q1, 2026)
- ¥41.9M
- Enterprise value
- $7.1B